We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Preventing Sexual Aggression Among High School Boys

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02506088
Recruitment Status : Active, not recruiting
First Posted : July 22, 2015
Last Update Posted : August 29, 2017
Information provided by (Responsible Party):
Lindsay Orchowski Ph.D., Lifespan

Brief Summary:
The present research creates a partnership between researchers and a community agency to evaluate whether a sexual assault prevention program for high school students reduces perpetration of sexual violence among high school boys.

Condition or disease Intervention/treatment
Violence Behavioral: Your Voice Your View

Detailed Description:

The present research advances the science of sexual assault prevention by creating a mutually beneficial partnership between well-established sexual assault prevention researchers and a CDC Rape Prevention and Education Program (RPE)-funded community agency to conduct a rigorous experimental evaluation of universal primary prevention programming designed to reduce sexual aggression among high school boys. The present research tests multi-session prevention programming that targets change at multiple levels of the social ecology (i.e., individual-, peer- and community-level) through social norms theory and bystander education. Specifically, the present research evaluates Your Voice Your View. Your Voice Your View was developed and is currently administered in Rhode Island High Schools by the CDC RPE-funded agency Day One of Rhode Island. The program will be tested in a group randomized cluster trial among 10th graders at 30 high schools, with the aim of reducing perpetration of sexual aggression among high school boys.

Specifically, this research will conduct a randomized controlled trial with a sample of 10th grade students to demonstrate efficacy of the intervention in reducing rates of sexual aggression among high school boys, rates of dating violence involvement, and related risk and protective factors over a 2- and 6-month follow-up in comparison to a wait-list control group. Thirty schools will be matched on demographic characteristics (i.e., % receiving subsidized lunch, racial/ethnic minority enrollment) and randomized to receive Your Voice Your View or to the wait-list control group.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 9000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Preventing Sexual Aggression Among High School Boys
Study Start Date : September 2015
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 2018

Arm Intervention/treatment
Experimental: Your Voice Your View
Participants in schools assigned to the treatment group will engage in a four session intervention aimed at prevention of sexual violence. Your Voice Your View is grounded in social norms theory and bystander intervention training. The intervention also includes a social norms marketing campaign.
Behavioral: Your Voice Your View
Session 1 of the intervention involves background information, an introduction to social norms, and bystander intervention skills training. Session 2 of the intervention establishes conditions for consent, types of abusive behavior and identifying abuse. Session 3 of the intervention addresses risk reduction strategies for girls. Session 3 of the intervention addresses false accusations, masculinity, and additional practice on identifying conditions for consent for boys. Session 4 of the intervention includes active practice of bystander intervention skills.
No Intervention: Wait List Control Group
Participants in schools assigned to the wait list control group will complete survey assessments at the same schedule as schools assigned to the treatment group. Schools will have the option to implement Your Voice Your View following completion of the 6-month survey.

Primary Outcome Measures :
  1. Perpetration of Sexual Violence Survey [ Time Frame: up to 6-months ]

Secondary Outcome Measures :
  1. Rate of Dating Violence Perpetration [ Time Frame: up to 6 months ]
  2. Rape Myth Acceptance Survey [ Time Frame: up to 6 months ]
  3. Bystander Intervention Skills Survey [ Time Frame: up to 6 months ]
    Composite measure: Increase Positive Bystander Behavior, Decrease Barriers to Intervening, Increase Likelihood of Intervening

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Adolescents at Rhode Island high schools will be eligible for enrollment according to the following criteria: 1) adolescent assent given; 3) passive consent of a parent/legal guardian is given. Teachers will be eligible to participate in educator assessments if consent is given.

Exclusion Criteria:

  • There are no exclusion criteria.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02506088

United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02904
Sponsors and Collaborators
Principal Investigator: Lindsay M. Orchowski, Ph.D. Rhode Island Hospital

Responsible Party: Lindsay Orchowski Ph.D., Staff Psychologist, Lifespan
ClinicalTrials.gov Identifier: NCT02506088     History of Changes
Other Study ID Numbers: 1U01CE002531 ( U.S. NIH Grant/Contract )
First Posted: July 22, 2015    Key Record Dates
Last Update Posted: August 29, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Behavioral Symptoms